Adi Intellect
0
0
1
Irritable bowel syndrome (IBS) is a digestive system disorder in which a person experiences multiple symptoms that impacts his/her daily life. Irritable bowel syndrome affects 10-15% of the population around the world, but the exact cause of IBS is unknown. The occurrence of IBS is higher in women than in men. People with a prior digestive tract infection, stressful lifestyle, and family history of IBS are more likely to develop the disorder [NIH]. Irritable bowel syndrome is of three types – irritable bowel syndrome with diarrhea (IBS-D), irritable bowel syndrome with constipation (IBS-C) and irritable bowel syndrome with alternating constipation and diarrhea (IBS-A). Read More
0
0
1
Adi Intellect
From the Author
Related Articles
According to Market Research Future (MRFR)’s new study, the global irritable bowel syndrome treatment market is projected to thrive at a CAGR of 7. Furthermore, the collaborations among the key players are supposed to have a positive influence on the proliferation of the irritable bowel syndrome treatment market. com/sample_request/7044 Global Market for Irritable Bowel Syndrome Treatment – Competitive Dashboard:Some of the key players profiled in the report are Abbott, Allergan Inc. By drug type, the irritable bowel syndrome treatment market has been segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, alosetron, and others. The irritable bowel syndrome treatment market in Asia Pacific is poised to witness significant growth in the upcoming years.
0
1
According to Market Research Future (MRFR)’s new study, the global irritable bowel syndrome treatment market is projected to thrive at a CAGR of 7. Furthermore, the collaborations among the key players are supposed to have a positive influence on the proliferation of the irritable bowel syndrome treatment market. com/sample_request/7044 Global Market for Irritable Bowel Syndrome Treatment – Segmental analysis:This MRFR report offers a detailed segmental analysis of the global irritable bowel syndrome treatment market based on type, drug type, and end-user. By drug type, the irritable bowel syndrome treatment market has been segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, alosetron, and others. The irritable bowel syndrome treatment market in Asia Pacific is poised to witness significant growth in the upcoming years.
0
1
Let's know more about what causes IBS and hypnosis techniques for IBS treatment:What Causes IBS? Studies have shown that hypnosis can effectively reduce IBS symptoms such as bloating, abdominal pain, and diarrhea and that the benefits can be long-lasting. In hypnotherapy for IBS, patients may be guided through a series of mental exercises in which they imagine themselves in a peaceful, relaxing environment. DesensitizationDesensitization is a technique in which patients are gradually exposed to the things that trigger their IBS symptoms. Gut-Directed HypnotherapyGut-directed hypnotherapy is a specific type of hypnotherapy tailored to IBS patients' needs.
0
1